Ghent University Academic Bibliography

Advanced

Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

J Bousquet, J Farrell, G Crooks, P Hellings, EH Bel, M Bewick, NH Chavannes, J Correia de Sousa, AA Cruz, T Haahtela, et al. (2016) CLINICAL AND TRANSLATIONAL ALLERGY. 6.
abstract
Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) focuses on the integrated care of chronic diseases. Area 5 (Care Pathways) was initiated using chronic respiratory diseases as a model. The chronic respiratory disease action plan includes (1) AIRWAYS integrated care pathways (ICPs), (2) the joint initiative between the Reference site MACVIA-LR (Contre les MAladies Chroniques pour un Vleillissement Actif) and ARIA (Allergic Rhinitis and its Impact on Asthma), (3) Commitments for Action to the European Innovation Partnership on Active and Healthy Ageing and the AIRWAYS ICPs network. It is deployed in collaboration with the World Health Organization Global Alliance against Chronic Respiratory Diseases (GARD). The European Innovation Partnership on Active and Healthy Ageing has proposed a 5-step framework for developing an individual scaling up strategy: (1) what to scale up: (1-a) databases of good practices, (1-b) assessment of viability of the scaling up of good practices, (1-c) classification of good practices for local replication and (2) how to scale up: (2-a) facilitating partnerships for scaling up, (2-b) implementation of key success factors and lessons learnt, including emerging technologies for individualised and predictive medicine. This strategy has already been applied to the chronic respiratory disease action plan of the European Innovation Partnership on Active and Healthy Ageing.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (review)
publication status
published
subject
keyword
EIP on AHA, European Innovation Partnership on Active and Healthy Ageing, Chronic respiratory diseases, AIRWAYS ICPs, MACVIA, ARIA, Scaling up, UPDATE ARIA 2008, ALLERGIC RHINITIS, SEVERE ASTHMA, GLOBAL ALLIANCE, OPERATIONAL DEFINITION, SYSTEMS MEDICINE, LANGUEDOC-ROUSSILLON, REFERENCE SITE, GINA STRATEGY, AIRWAYS-ICPS
journal title
CLINICAL AND TRANSLATIONAL ALLERGY
Clin. Transl. Allergy
volume
6
article number
29
pages
18 pages
Web of Science type
Review
Web of Science id
000390119300001
JCR category
ALLERGY
JCR impact factor
3.239 (2016)
JCR rank
12/26 (2016)
JCR quartile
2 (2016)
ISSN
2045-7022
DOI
10.1186/s13601-016-0116-9
language
English
UGent publication?
yes
classification
A1
additional info
correction published in: Clin. Transl. Allergy (2017) 7:5 ; DOI 10.1186/s13601-016-0135-6 [Kaitov should read Khaitov]
copyright statement
Creative Commons Attribution 4.0 International Public License (CC-BY 4.0)
id
8500390
handle
http://hdl.handle.net/1854/LU-8500390
date created
2017-01-03 15:27:08
date last changed
2017-09-06 14:28:38
@article{8500390,
  abstract     = {Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) focuses on the integrated care of chronic diseases. Area 5 (Care Pathways) was initiated using chronic respiratory diseases as a model. The chronic respiratory disease action plan includes (1) AIRWAYS integrated care pathways (ICPs), (2) the joint initiative between the Reference site MACVIA-LR (Contre les MAladies Chroniques pour un Vleillissement Actif) and ARIA (Allergic Rhinitis and its Impact on Asthma), (3) Commitments for Action to the European Innovation Partnership on Active and Healthy Ageing and the AIRWAYS ICPs network. It is deployed in collaboration with the World Health Organization Global Alliance against Chronic Respiratory Diseases (GARD). The European Innovation Partnership on Active and Healthy Ageing has proposed a 5-step framework for developing an individual scaling up strategy: (1) what to scale up: (1-a) databases of good practices, (1-b) assessment of viability of the scaling up of good practices, (1-c) classification of good practices for local replication and (2) how to scale up: (2-a) facilitating partnerships for scaling up, (2-b) implementation of key success factors and lessons learnt, including emerging technologies for individualised and predictive medicine. This strategy has already been applied to the chronic respiratory disease action plan of the European Innovation Partnership on Active and Healthy Ageing.},
  articleno    = {29},
  author       = {Bousquet, J and Farrell, J and Crooks, G and Hellings, P and Bel, EH and Bewick, M and Chavannes, NH and de Sousa, J Correia and Cruz, AA and Haahtela, T and Joos, Guy and Khaltaev, N and Malva, J and Muraro, A and Nogues, M and Palkonen, S and Pedersen, S and Robalo-Cordeiro, C and Samolinski, B and Strandberg, T and Valiulis, A and Yorgancioglu, A and Zuberbier, T and Bedbrook, A and Aberer, W and Adachi, M and Agusti, A and Akdis, CA and Akdis, M and Ankri, J and Alonso, A and Annesi-Maesano, I and Ansotegui, IJ and Anto, JM and Arnavielhe, S and Arshad, H and Bai, C and Baiardini, I and Bachert, Claus and Baigenzhin, AK and Barbara, C and Bateman, ED and Begh{\'e}, B and Ben Kheder, A and Bennoor, KS and Benson, M and Bergmann, KC and Bieber, T and Bindslev-Jensen, C and Bjermer, L and Blain, H and Blasi, F and Boner, AL and Bonini, M and Bonini, S and Bosnic-Anticevitch, S and Boulet, LP and Bourret, R and Bousquet, PJ and Braido, F and Briggs, AH and Brightling, CE and Brozek, J and Buhl, R and Burney, PG and Bush, A and Caballero-Fonseca, F and Caimmi, D and Calderon, MA and Calverley, PM and Camargos, PAM and Canonica, GW and Camuzat, T and Carlsen, KH and Carr, W and Carriazo, A and Casale, T and Cepeda Sarabia, AM and Chatzi, L and Chen, YZ and Chiron, R and Chkhartishvili, E and Chuchalin, AG and Chung, KF and Ciprandi, G and Cirule, I and Cox, L and Costa, DJ and Custovic, A and Dahl, R and Dahlen, SE and Darsow, U and De Carlo, G and De Blay, F and Dedeu, T and Deleanu, D and De Manuel Keenoy, E and Demoly, P and Denburg, JA and Devillier, P and Didier, A and Dinh-Xuan, AT and Djukanovic, R and Dokic, D and Douagui, H and Dray, G and Dubakiene, R and Durham, SR and Dykewicz, MS and El-Gamal, Y and Emuzyte, R and Fabbri, LM and Fletcher, M and Fiocchi, A and Fink Wagner, A and Fonseca, J and Fokkens, WJ and Forastiere, F and Frith, P and Gaga, M and Gamkrelidze, A and Garces, J and Garcia-Aymerich, J and Gemicio\u{g}lu, B and Gereda, JE and Gonz{\'a}lez Diaz, S and Gotua, M and Grisle, I and Grouse, L and Gutter, Z and Guzm{\'a}n, MA and Heaney, LG and Hellquist-Dahl, B and Henderson, D and Hendry, A and Heinrich, J and Heve, D and Horak, F and Hourihane, JO{\textquoteright}B and Howarth, P and Humbert, M and Hyland, ME and Illario, M and Ivancevich, JC and Jardim, JR and Jares, EJ and Jeandel, C and Jenkins, C and Johnston, SL and Jonquet, O and Julge, K and Jung, KS and Just, J and Kaidashev, I and Khaitov, MR and Kalayci, O and Kalyoncu, AF and Keil, T and Keith, PK and Klimek, L and Koffi N{\textquoteright}Goran, B and Kolek, V and Koppelman, GH and Kowalski, ML and Kull, I and Kuna, P and Kvedariene, V and Lambrecht, Bart and Lau, S and Larenas-Linnemann, D and Laune, D and Le, LTT and Lieberman, P and Lipworth, B and Li, J and Lodrup Carlsen, K and Louis, R and MacNee, W and Magard, Y and Magnan, A and Mahboub, B and Mair, A and Majer, I and Makela, MJ and Manning, P and Mara, S and Marshall, GD and Masjedi, MR and Matignon, P and Maurer, M and Mavale-Manuel, S and Mel{\'e}n, E and Melo-Gomes, E and Meltzer, EO and Menzies-Gow, A and Merk, H and Michel, JP and Miculinic, N and Mihaltan, F and Milenkovic, B and Mohammad, GMY and Molimard, M and Momas, I and Montilla-Santana, A and Morais-Almeida, M and Morgan, M and M{\"o}sges, R and Mullol, J and Nafti, S and Namazova-Baranova, L and Naclerio, R and Neou, A and Neffen, H and Nekam, K and Niggemann, B and Ninot, G and Nyembue, TD and O{\textquoteright}Hehir, RE and Ohta, K and Okamoto, Y and Okubo, K and Ouedraogo, S and Paggiaro, P and Pali-Sch{\"o}ll, I and Panzner, P and Papadopoulos, N and Papi, A and Park, HS and Passalacqua, G and Pavord, I and Pawankar, R and Pengelly, R and Pfaar, O and Picard, R and Pigearias, B and Pin, I and Plavec, D and Poethig, D and Pohl, W and Popov, TA and Portejoie, F and Potter, P and Postma, D and Price, D and Rabe, KF and Raciborski, F and Radier Pontal, F and Repka-Ramirez, S and Reitamo, S and Rennard, S and Rodenas, F and Roberts, J and Roca, J and Rodriguez Ma{\~n}as, L and Rolland, C and Roman Rodriguez, M and Romano, A and Rosado-Pinto, J and Rosario, N and Rosenwasser, L and Rottem, M and Ryan, D and Sanchez-Borges, M and Scadding, GK and Schunemann, HJ and Serrano, E and Schmid-Grendelmeier, P and Schulz, H and Sheikh, A and Shields, M and Siafakas, N and Sibille, Y and Similowski, T and Simons, FER and Sisul, JC and Skrindo, I and Smit, HA and Sol{\'e}, D and Sooronbaev, T and Spranger, O and Stelmach, R and Sterk, PJ and Sunyer, J and Thijs, C and To, T and Todo-Bom, A and Triggiani, M and Valenta, R and Valero, AL and Valia, E and Valovirta, E and Van Ganse, E and van Hage, M and Vandenplas, O and Vasankari, T and Vellas, B and Vestbo, J and Vezzani, G and Vichyanond, P and Viegi, G and Vogelmeier, C and Vontetsianos, T and Wagenmann, M and Wallaert, B and Walker, S and Wang, DY and Wahn, U and Wickman, M and Williams, DM and Williams, S and Wright, J and Yawn, BP and Yiallouros, PK and Yusuf, OM and Zaidi, A and Zar, HJ and Zernotti, ME and Zhang, L and Zhong, N and Zidarn, M and Mercier, J},
  issn         = {2045-7022},
  journal      = {CLINICAL AND TRANSLATIONAL ALLERGY},
  keyword      = {EIP on AHA,European Innovation Partnership on Active and Healthy Ageing,Chronic respiratory diseases,AIRWAYS ICPs,MACVIA,ARIA,Scaling up,UPDATE ARIA 2008,ALLERGIC RHINITIS,SEVERE ASTHMA,GLOBAL ALLIANCE,OPERATIONAL DEFINITION,SYSTEMS MEDICINE,LANGUEDOC-ROUSSILLON,REFERENCE SITE,GINA STRATEGY,AIRWAYS-ICPS},
  language     = {eng},
  pages        = {18},
  title        = {Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)},
  url          = {http://dx.doi.org/10.1186/s13601-016-0116-9},
  volume       = {6},
  year         = {2016},
}

Chicago
Bousquet, J, J Farrell, G Crooks, P Hellings, EH Bel, M Bewick, NH Chavannes, et al. 2016. “Scaling up Strategies of the Chronic Respiratory Disease Programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).” Clinical and Translational Allergy 6.
APA
Bousquet, J, Farrell, J., Crooks, G., Hellings, P., Bel, E., Bewick, M., Chavannes, N., et al. (2016). Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5). CLINICAL AND TRANSLATIONAL ALLERGY, 6.
Vancouver
1.
Bousquet J, Farrell J, Crooks G, Hellings P, Bel E, Bewick M, et al. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5). CLINICAL AND TRANSLATIONAL ALLERGY. 2016;6.
MLA
Bousquet, J, J Farrell, G Crooks, et al. “Scaling up Strategies of the Chronic Respiratory Disease Programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).” CLINICAL AND TRANSLATIONAL ALLERGY 6 (2016): n. pag. Print.